Maité F.
- Country
- France
- Department
- Neurology
Research Overview
Data & Insights
Has run more than one trial at 0 of 9 partner sites.
Specializations
Neurovascular and Stroke Care
Maité Formaglio investigates acute ischemic stroke and its acute management in adult patients.
- Large-vessel occlusion therapies
- Transient ischemic attack prevention
- Post‑resuscitation neurological outcomes
Her work integrates advanced imaging and neurocritical care pathways.
Neurodegenerative and Movement Disorders
The investigator addresses early Parkinson’s disease progression and related cognitive decline.
- Biomarker‑guided disease staging
- Motor symptom modulation
- Neuroprotective therapeutic trials
Collaboration with regional memory clinics enhances patient recruitment.
Sleep‑Related Breathing Disorders and Metabolic Health
She leads studies on moderate to severe obstructive sleep apnea in overweight and obese adults.
- CPAP adherence optimization
- Cardiometabolic risk reduction
- Impact on daytime neurocognitive function
Research is conducted across the two affiliated university hospitals.
Oncology and Solid Tumor Research
Formaglio contributes to clinical programs targeting advanced solid tumors, including lung and gastrointestinal cancers.
- Targeted therapy in KRAS‑mutated NSCLC
- Immunotherapy combinations for metastatic melanoma
- Biomarker‑driven enrollment in rare tumor cohorts
Her neurology expertise supports neuro‑oncology symptom management.
Hematologic Malignancies and Immune Disorders
She focuses on therapeutic strategies for acute lymphoblastic leukemia and systemic autoimmune diseases.
- Novel agents for IDH1‑mutated AML
- Biologic treatments for systemic lupus erythematosus
- Graft‑versus‑host disease mitigation
Multidisciplinary collaboration with hematology units underpins trial execution.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.